Introduction
Schizophrenia is a psychiatric disorder with a lifetime prevalence estimate of 0.6% of and contributes substantially to morbidity, mortality and social disability.1 Current therapeutic options primarily target dopaminergic signaling,…

Schizophrenia is a psychiatric disorder with a lifetime prevalence estimate of 0.6% of and contributes substantially to morbidity, mortality and social disability.1 Current therapeutic options primarily target dopaminergic signaling,…